Loading...

Categories

28 Philippines Pharmaceuticals Reports

Philippines Diabetes Care Drugs Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk

APAC Insulin Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

Asia Pacific DPP Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb

Asia-Pacific GLP 1 Agonist Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.

Diabetes Drug Market in Asia Pacific

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

APAC Meglitinide Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Asia-Pacific Alpha-Glucosidase Inhibitors Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Asia-Pacific Oral Anti-Diabetic Drug Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen

Insulin Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Diabetes Care Drugs Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

DPP4 Drugs Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

GLP-1 Agonists Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.

Oral Antidiabetic Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Alpha Glucosidase Inhibitor Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

Biguanides Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Diabetes Combination Drugs Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Meglitinides Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Glargine Insulin Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Wegovy Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S

Ozempic Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Liraglutide Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Injectable Anti-diabetic Drugs Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Novo Nordisk, Lilly, Julphar, Biocon, Sanofi

Trulicity Market

Country Covered: Philippines

Study Period: 2021-2029

Major Players: Eli Lilly